AIM ImmunoTech Inc. (AIM) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

AIM ImmunoTech Inc. (AIM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.4M, listed on AMEX, employing roughly 21 people, carrying a beta of 1.24 to the broader market. AIM ImmunoTech Inc. Led by Thomas K. Equels, public since 1995-11-02.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for AIM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →